GLP-1 S (20mg)

Product Overview:

• GLP-1 S (20mg) is a research-grade peptide formulated to aid scientific exploration of GLP-1 receptor agonists in metabolic and endocrinological studies.
• The 20mg formulation provides researchers with an adequate dose for studies involving high-dose protocols or extended research timelines.
• GLP-1 S (20mg) is not FDA-approved for therapeutic use and is available exclusively for research purposes.

Key Features:

• Research-Grade Compound: Specifically designed for use in scientific research, this peptide is intended to aid in studies of metabolic diseases such as type 2 diabetes, obesity, and other related conditions.
• Precise Dosage: The product comes in a 20mg dose, allowing flexibility for a range of research applications, including dose-response studies and long-term studies.
• Investigation of GLP-1 Agonists: The peptide is used to explore the pharmacodynamics and pharmacokinetics of GLP-1 receptor activation and its implications for insulin secretion and glucose regulation.

Research Applications:

• Metabolic Studies: Investigating how GLP-1 S influences insulin sensitivity, glucose metabolism, and lipid regulation to improve understanding of metabolic conditions like type 2 diabetes and insulin resistance.
• Appetite Regulation: Studying how GLP-1 receptor activation affects satiety, food intake, and overall energy balance, with potential applications in obesity and weight management research.
• Endocrine Research: Understanding the broader role of GLP-1 analogs in regulating gastrointestinal hormones and their impact on metabolic homeostasis.
• Pharmacological Investigations: Research on the pharmacokinetics and pharmacodynamics of GLP-1 S in various animal models, including its effect on glucose control and energy expenditure.